Avmapki Fakzynja Co-pack Kit
Product Images NDC 71779-623

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Avmapki Fakzynja Co-pack (NDC 71779-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Verastem Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Avmapki 01)

FDA Label Image

Chemical Structure (Avmapki 02)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This is the description: This text provides information about two medications: AVMAPKI™ and FAKZYNIA™. AVMAPKI™ capsules contain Avutometind 0.8 mg, while FAKZYNIA™ tablets contain Daactinb 200 mg. The recommended dosage for the AVMAPKI™ FAKZYNIA™ co-pack is mentioned. It is advised to refer to the prescribing information inside the carton. The medications should be stored refrigerated at 2°C to 8°C. The text also includes the manufacturer's details, contact information, and a website for further information. The text mentions that the carton contains AVMAPKI™ (24 capsules) and FAKZYNIA™ (2 tablets). Additionally, there are references to NDC numbers and dosing instructions.*
FDA Label Image

Principal Display Panel (0.8 mg Capsule Bottle Label)

Principal Display Panel (0.8 mg Capsule Bottle Label)
Each capsule contains Avutometinib 08 mg, part of the Khomeinisrasson AVMAPKI™ medication. It is recommended to keep the capsules refrigerated and stored in the original bottle. The dosage information can be found on the printed prescribing information inside the carton. Make sure to not use if the seal under the cap is broken or missing. The medication is manufactured by Verastem, Inc. and should be kept out of reach of children. If you require further information, you can contact toll-free number 1-677-878-6662 or visit their website at www.AvmapkiFakzynjaCo-Pack.com.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
Each tablet contains: NDC71779630.01 Rxonly Recommended Dosage: See Defactinib 200 mg (equivalent t0 21436 mg printed Prescribing Information Defaciinib Hydrochloride) inside the carton. This text contains information about a medication named Defactinib, its dosage, and the proper way to store and handle the tablets. It is also mentioned that the tablets should not be chewed, broken, or crushed. Contact information for further assistance is provided at the end of the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.